Nearly all ANCA-associated vasculitis (AAV) patients undergoing a bronchoscopy — a minimally invasive procedure to examine the lungs and air…
Articles by Steve Bryson, PhD
The ANCA Renal Risk Score (ARRS) — based on kidney biopsy and lab results — could accurately predict kidney failure…
Two years of treatment with Nucala (mepolizumab) safely and effectively reduces signs and symptoms of hard-to-treat eosinophilic granulomatosis with…
Urine levels of scarring, inflammation, and kidney damage biomarkers accurately reflect kidney biopsy results and predict kidney outcomes in people…
The incidence of ANCA-associated vasculitis (AAV) in southern Sweden was stable over a 23-year period, while its prevalence, the…
A specific variant in both copies of the gene that codes for proteinase 3 (PR3) — one of the most…
The European Alliance of Associations for Rheumatology (EULAR) has updated its recommendations on managing ANCA-associated vasculitis (AAV) based…
Concerns about the future, their disease’s social and emotional impact, and bodywide symptoms were prominent among those reported by ANCA-associated…
Tavneos (avacopan) effectively reverses severe kidney disease associated with ANCA-associated vasculitis (AAV) compared with standard steroid therapy, according…
Patients with ANCA-associated vasculitis (AAV) have a higher risk of mortality than the general population, especially those who are…